Protocols
1 protocol(s) meet the specified criteria
Drug: Entinostat
Protocol No.TitleStatus
LCCC1639A non-randomized, non-comparative, open-label, window trial of entinostat given with or without exemestane in patients with newly diagnosed, Stage I-IIIC, hormone receptor – positive (HR+) or triple negative breast cancer (TNBC)Open